My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Oklahoma cancel Social and Behavioral Health cancel New Jersey cancel Population Health and Prevention cancel

COVID-19 and Beyond: Improving Youth Mental Health Outcomes and Disparities

Infectious Disease,
COVID-19,
COVID and Mental Health,
COVID and Special Populations,
COVID and Health Equity/Health Disparities,
Blog,
Health Policy Update,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
Suicide Prevention,
Health Equity,
Social Determinants of Health,
At-Risk Populations,
Women, Infant, and Family Health,
Preparedness,
Pandemics,
Ioana Ungureanu,
Communications,
Public Health Infrastructure and Systems Improvement,
LGBTQ+,
Race and Public Health,
Healthcare Access,
Medicaid and Public Health Partnerships,
Arkansas,
Georgia,
Hawaii,
Indiana,
Nevada,
New Jersey,
New York,
Oklahoma,
Utah,
Washington,
Policy,
State Health Policy

The COVID-19 pandemic has impacted both the physical and mental health well-being of youth. Disruptions in both their home and school life have put youth at risk for poor mental health outcomes that include increased anxiety, depression, ...

Voters Decide on Health-Related Ballot Proposals

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
Tobacco Control,
Substance Misuse,
Arizona,
Colorado,
Washington, D.C.,
Mississippi,
Montana,
New Jersey,
Oklahoma,
Oregon,
South Dakota,
Andy Baker-White

In the November 2020 election, voters in several states cast their ballots on proposals related to the use of legal and illicit drugs. These ballot proposals influence key public health issues such as tobacco control, substance use ...

How States are Preparing for Opioid Settlement Funds

Blog,
Health Policy Update,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Opioids,
Overdose Prevention,
Women, Infant, and Family Health,
Policy,
State Health Policy,
Funding,
Public Health Law,
Kentucky,
Massachusetts,
New Jersey,
New York,
Ohio,
Oklahoma,
Virginia,
Victoria Pless,
Healthcare Access,
Public Health Infrastructure and Systems Improvement,
Grants and Contracts Management,
Partnership

The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated that 67,367 people died of overdose, with ...

ASTHO’s 2024 Legislative Session Update: Part One

Blog,
Data Modernization,
Arizona,
Policy,
Health Policy Update,
State Health Policy,
Health Equity,
Environmental Health,
New Hampshire,
Oklahoma,
Maine,
Florida,
Colorado,
Tennessee,
Virginia,
Wisconsin,
California,
New Jersey,
Missouri,
Maryland,
New York,
Georgia,
Delaware,
New Mexico,
Hawaii,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
STIs,
Women, Infant, and Family Health,
Infant and Child Health,
Lillian Colasurdo,
Maggie Davis,
Lana McKinney,
JoAnne McClure

ASTHO’s 2024 Legislative Session Update: Part One legislative session, state policy, data collection, domestic violence, health information exchange, data privacy, substance misuse, overdose prevention, sexually transmitted infections, ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...